China’s WuXi Biologics to sell vaccine facility to Merck for US$500 million
WUXI Biologics Cayman will sell a vaccine facility in Ireland to Merck for about US$500 million as the Chinese company ...
WUXI Biologics Cayman will sell a vaccine facility in Ireland to Merck for about US$500 million as the Chinese company ...
MERCK snagged a potential drug in the burgeoning market for obesity medications in a deal worth as much as US$2 ...
MERCK & Co licenced an experimental cancer antibody from a closely held Chinese company in a deal worth US$588 million ...
MERCK lowered the top end of its full-year sales guidance after demand for its HPV vaccine fell for a second ...
© 2024 forbes50under50 - All Rights Reserved.
© 2024 forbes50under50 - All Rights Reserved.